Mongolia Health Clinical Trials Mongolia Health RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial
Condition:   SARS-CoV-2 Infection Interventions:   Drug: Azvudine;   Drug: Paxlovid group Sponsors:   Southeast University, China;   Hohhot First Hospital, Hohhot, Inner Mongolia, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials